Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Operating Margin (2019 - 2023)

Benitec Biopharma (BNTC) has disclosed Operating Margin for 5 consecutive years, with 65000.0% as the latest value for Q2 2023.

  • Quarterly Operating Margin changed N/A to 65000.0% in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 307028.57% through Mar 2024, down 27869181.0% year-over-year, with the annual reading at 25441.33% for FY2023, 98380.0% down from the prior year.
  • Operating Margin hit 65000.0% in Q2 2023 for Benitec Biopharma, down from 8038.89% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 8248.57% in Q2 2020 to a low of 379300.0% in Q1 2021.
  • Historically, Operating Margin has averaged 80620.4% across 5 years, with a median of 8038.89% in 2023.
  • Biggest five-year swings in Operating Margin: plummeted -37176071bps in 2021 and later soared 37209167bps in 2022.
  • Year by year, Operating Margin stood at 2741.56% in 2019, then crashed by -11787bps to 325900.0% in 2020, then surged by 94bps to 19340.0% in 2021, then tumbled by -107bps to 40071.43% in 2022, then tumbled by -62bps to 65000.0% in 2023.
  • Business Quant data shows Operating Margin for BNTC at 65000.0% in Q2 2023, 8038.89% in Q1 2023, and 40071.43% in Q4 2022.